Part Number
Part Number:
NSN:
NIIN:
Item Name:
CYCLOPHOSPHAMIDE TABLETS , USP
Definition:
CAGE Information
| Code | Company |
|---|---|
| 0NUD3 | BRISTOL-MYERS SQUIBB COMPANY DBA BRI |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CYCLOPHOSPHAMIDE TABLETS USP 25MG 100S BT 12 PER PG |
| AJCN | PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 12 |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 25.000 MILLIGRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT |
| FEAT | SPECIAL FEATURES | NOTE: D |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| CBBL | FEATURES PROVIDED | CHILD RESISTANT CLOSURE |